皇家华人

header-logo
GettyImages-609179959-hero
headshot

Lubna N. Chaudhary, MD

Associate Professor

view physician profile

Locations

  • Froedtert Hospital
  • Breast Care Center - Cancer Center - Froedtert Hospital
  • Cancer Center - Froedtert Menomonee Falls Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Urdu, Hindi

Breast Care Center

Cancer Center - Froedtert Hospital

Cancer Center - Froedtert Menomonee Falls Hospital

New Patient Appointments - Breast

Education

  • MD - Doctor of Medicine

Biography

Lubna Chaudhary, MD, MS, is an assistant professor of medicine at the 皇家华人 Division of Hematology and Oncology. She graduated from King Edward Medical College, Pakistan. She completed residency in Internal Medicine from West Virginia University and a fellowship in hematology/oncology from Froedtert & the 皇家华人 (MCW). She also obtained a Masters degree in Clinical and Translational Science through CTSI at MCW. Dr. Chaudhary is board certified in Internal Medicine and Medical Oncology. She has authored numerous peer reviewed publications and is actively involved in breast cancer clinical trials.

Research Interests

Dr. Chaudhary's primary research focus is to understand and study breast cancer tumor biology, association of receptor status with patient outcomes and breast cancer developmental therapeutics. She is the primary investigator of many ongoing breast cancer clinical trials. She treats breast cancer patients at the Froedtert & the 皇家华人 Breast Care Center as well as at Froedtert Menomonee Falls Hospital. She is also responsible for co-management of the Hereditary Cancer Management clinic, with a specific focus on breast cancers.

Publications

  • (Krishnan J, Patel A, Roy AM, Alharbi M, Kapoor A, Yao S, Khoury T, Hong CC, Held N, Chakraborty A, Kaliniski P, Salman A, Catalfamo K, Attwood K, Kirtani V, Shaikh SS, Chaudhary LN, Gandhi S.) Clin Breast Cancer. 2024 Dec;24(8):e701-e711.e2 PMID: 39198116 SCOPUS ID: 2-s2.0-85202494820 08/31/2024

  • (Alaklabi S, Roy AM, Zagami P, Chakraborty A, Held N, Elijah J, George A, Attwood K, Shaikh SS, Chaudhary LN, Abdou Y, Gandhi S.) JCO Oncol Pract. 2024 Oct 01:OP2400242 PMID: 39353151 10/03/2024

  • (Valencia EA, Cortina CS, Cobb AN, Chaudhary LN, Kelly T, Kong AL.) Ann Surg Open. 2024 Sep;5(3):e465 PMID: 39310356 PMCID: PMC11415127 09/23/2024

  • (Jorns JM, Sun Y, Kamaraju S, Cheng YC, Kong A, Yen T, Patten CR, Cortina CS, Chitambar CR, Rui H, Chaudhary LN.) J Pers Med. 2024 Apr 29;14(5) PMID: 38793060 PMCID: PMC11121947 SCOPUS ID: 2-s2.0-85194400127 05/25/2024

  • (Gonzalez T, Nie Q, Chaudhary LN, Basel D, Reddi HV.) Cancer Genet. 2024 Apr;282-283:1-8 PMID: 38134587 SCOPUS ID: 2-s2.0-85180559446 12/22/2023

  • (Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS.) Breast Cancer Res Treat. 2024 Jan;203(2):317-328 PMID: 37864105 PMCID: PMC10872271 SCOPUS ID: 2-s2.0-85174540456 10/21/2023

  • (Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN.) WMJ. 2023 Dec;122(5):418-421 PMID: 38180937 SCOPUS ID: 2-s2.0-85181850540 01/05/2024

  • (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H.) Breast Cancer Res Treat. 2023 Oct;201(3):387-396 PMID: 37460683 PMCID: PMC10795510 SCOPUS ID: 2-s2.0-85164922339 07/18/2023

  • (Chaudhary LN, Jorns J, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo M, Kong A, Patten C, Yen T, Cortina C, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H.) Res Sq. 2023 Apr 07 PMID: 37066270 PMCID: PMC10104267 04/18/2023

  • (Pierro MJ, Zhang AJ, Chaudhary LN.) JAMA Oncol. 2023 Apr 01;9(4):564-565 PMID: 36795394 SCOPUS ID: 2-s2.0-85153412803 02/17/2023

  • (Alaklabi S, Roy AM, Chaudhary LN, Gandhi S.) Explor Target Antitumor Ther. 2023;4(6):1301-1309 PMID: 38213539 PMCID: PMC10776593 01/12/2024

  • (Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP, Rui H.) JCO Precis Oncol. 2023 Jan;7:e2100498 PMID: 36652667 PMCID: PMC9928763 SCOPUS ID: 2-s2.0-85159190085 01/19/2023

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.